Building Enduring Capabilities Through a Pioneering NLRP3 Biomarker Program 11/12/2025 Healthcare Access to innovation The development of novel biomarkers represents one of the most challenging frontiers in biotechnology, requiring the... Partners - VIVA IN VITRO
MedTech Barcelona: Highlights and Milestones of 2025 10/12/2025 Access to innovation Corporate New Product Launches: Custom Cell Plates & Shipping Media Partners - MedTech Barcelona
Biohope Announces Collaboration to Advance Immunobiogram Diagnostic Solution to Optimize I... 10/12/2025 Healthcare Access to innovation Biohope, a Spanish company specialized in personalized medicine solutions for transplant and autoimmune patients, has... Partners - Biohope
Viva In Vitro Diagnostics and Vall d’Hebron launch a new research project to enable early ... 09/12/2025 Healthcare Access to innovation The study will be conducted in the Intensive Care Medicine Service of the Vall d’Hebron University Hospital, led by Dr... Partners - VIVA IN VITRO
Adigital, AESEMI and AseBio drive a joint proposal to position Spain at the forefront of d... 25/11/2025 The three national associations have submitted a joint document to the Ministry of Science, Innovation and Universities... AseBio
Theriva™ Biologics anuncia varias presentaciones en congresos médicos 05/11/2025 Access to innovation VCN-01 expanded mPDAC data from VIRAGE Phase 2b trial to be presented at ESMO 2025 Partners - THERIVA BIOLOGICS S.L.
GENESIS Biomed participated in the strategic development of AptaTargets, which has license... 30/10/2025 Access to innovation Financing AptaTargets signed in May 2025 a licensing agreement with Merck for the clinical development and global... Partners - GENESIS Biomed
